氦离子和碳离子治疗过程中中子俘获增强剂量并降低照射野内外癌细胞活力
本研究首次实验验证中子俘获增强粒子治疗(NCEPT),以碳离子和氦离子束联合两种靶向中子俘获剂(NCA)照射人胶质母细胞瘤T98G细胞,发现加用NCA后治疗体积内细胞达10%存活所需剂量降低,治疗体积旁细胞也呈剂量依赖性生长抑制,且治疗体积中心测得热中子注量。
要点
- 碳或氦离子束联合NCA时,治疗体积内细胞达10%存活所需剂量低于无NCA时。
- 治疗体积旁细胞在NCA作用下呈剂量依赖性生长下降,达10%存活;无NCA时未检测到效应。
- NCEPT将中子俘获治疗药物与概念扩展至深部及弥漫肿瘤的靶向剂量递送。
核心结论
- 碳离子和氦离子束照射时向癌细胞加入NCA对体外细胞存活和生长有可测量的影响。
- 通过俘获体内产生的热中子,NCEPT引入将生化靶向辐射剂量引入带电粒子治疗的概念。
- NCEPT使中子俘获治疗的已有药物和概念可用于更广泛的深部和弥漫肿瘤,将剂量靶向至微浸润和定义治疗区域外的细胞。
- 结果还显示NCEPT有潜力提高治疗体积内肿瘤组织的剂量,同时降低非靶组织的辐射剂量。
研究设计与样本
- 本研究为NCEPT的首次实验演示,使用碳离子和氦离子束以及2种靶向中子俘获剂(NCA)。
- 人胶质母细胞瘤细胞(T98G)在[10B]-BPA和[157Gd]-DOTA-TPP存在下接受碳离子和氦离子束照射。
- 细胞置于聚甲基丙烯酸甲酯体模内,位于100×100×60 mm扩展布拉格峰(SOBP)的侧旁或内部。
- 通过6次独立实验的细胞生长和存活检测测量NCA及相对于SOBP位置对细胞的影响。
- 通过量化金箔的中子活化表征体模内的中子注量。
主要发现
- 治疗体积内细胞在NCA存在下,碳离子2 Gy或氦离子2至3 Gy即达10%存活,而无NCA时碳离子需5 Gy、氦离子需7 Gy。
- 治疗体积旁细胞在NCA处理下呈剂量依赖性生长下降,碳或氦离子(对治疗体积)6 Gy时达10%存活,而无NCA时未检测到对细胞的效应。
- SOBP中心平均热中子注量约为碳束2.2×10^9 n/cm2/Gy(相对生物效应),氦束5.8×10^9 n/cm2/Gy(相对生物效应),并向各方向逐渐降低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出这些结果为体外实验,NCEPT为提出的增强方法,尚未在临床中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Neutron capture enhanced particle therapy (NCEPT) is a proposed augmentation of charged particle therapy that exploits thermal neutrons generated internally, within the treatment volume via nuclear fragmentation, to deliver a biochemically targeted radiation dose to cancer cells. This work is the first experimental demonstration of NCEPT, performed using both carbon and helium ion beams with 2 different targeted neutron capture agents (NCAs). METHODS AND MATERIALS: Human glioblastoma cells (T98G) were irradiated by carbon and helium ion beams in the presence of NCAs [10B]-BPA and [157Gd]-DOTA-TPP. Cells were positioned within a polymethyl methacrylate phantom either laterally adjacent to or within a 100 × 100 × 60 mm spread out Bragg peak (SOBP). The effect of NCAs and location relative to the SOBP on the cells was measured by cell growth and survival assays in 6 independent experiments. Neutron fluence within the phantom was characterized by quantifying the neutron activation of gold foil. RESULTS: Cells placed inside the treatment volume reached 10% survival by 2 Gy of carbon or 2 to 3 Gy of helium in the presence of NCAs compared with 5 Gy of carbon and 7 Gy of helium with no NCA. Cells placed adjacent to the treatment volume showed a dose-dependent decrease in cell growth when treated with NCAs, reaching 10% survival by 6 Gy of carbon or helium (to the treatment volume), compared with no detectable effect on cells without NCA. The mean thermal neutron fluence at the center of the SOBP was approximately 2.2 × 109 n/cm2/Gy (relative biological effectiveness) for the carbon beam and 5.8 × 109 n/cm2/Gy (relative biological effectiveness) for the helium beam and gradually decreased in all directions. CONCLUSIONS: The addition of NCAs to cancer cells during carbon and helium beam irradiation has a measurable effect on cell survival and growth in vitro. Through the capture of internally generated neutrons, NCEPT introduces the concept of a biochemically targeted radiation dose to charged particle therapy. NCEPT enables the established pharmaceuticals and concepts of neutron capture therapy to be applied to a wider range of deeply situated and diffuse tumors, by targeting this dose to microinfiltrates and cells outside of defined treatment regions. These results also demonstrate the potential for NCEPT to provide an increased dose to tumor tissue within the treatment volume, with a reduction in radiation doses to off-target tissue.
引用
- Howell N, Middleton RJ, Sierro F, et al. Neutron Capture Enhances Dose and Reduces Cancer Cell Viability in and out of Beam During Helium and Carbon Ion Therapy. Int J Radiat Oncol Biol Phys. 2024. PMID: 38479560. doi:10.1016/j.ijrobp.2024.02.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。